Global Bone Growth Stimulator Market Overview 2023-2028
The global bone growth stimulator market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.05% during 2023-2028.
A bone growth stimulator is a medical equipment designed to aid and accelerate the natural healing process of bones. It utilizes various technologies, such as electrical stimulation, ultrasound, or magnetic fields, to promote bone growth and repair. It is used in orthopedic medicine for patients with fractures, non-unions (where bones fail to heal), and certain spinal conditions. It functions by delivering low-intensity electrical or electromagnetic signals to the affected area, which stimulate cellular activity and enhance the production of new bone tissue. It helps to expedite the healing process, reduces the need for surgical interventions, and improves patient outcomes.
Global Bone Growth Stimulator Market Trends and Drivers:
At present, the increasing prevalence of orthopedic conditions and injuries, along with the incidence of bone fractures, osteoporosis-related fractures, and spinal disorders, represents one of the crucial factors impelling the growth of the market. Besides this, the increasing demand for non-invasive, drug-free alternatives to traditional treatment methods is supporting the growth of the market. In addition, the growing investments in research and development (R&D) activities to enhance the effectiveness and convenience of bone growth stimulators are offering a favorable market outlook. Apart from this, the increasing number of sports-related injuries and road accidents is strengthening the growth of the market. Additionally, the rising number of sports-related injuries and road accidents is bolstering the growth of the market.
Global Bone Growth Stimulator Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation) and Zimmer Biomet
The report segmented the market on the basis of region, product, application and end user.
Breakup by Product:
- Bone Growth Stimulation Devices
- Bone Morphogenetic Proteins
- Platelet-Rich Plasma
Breakup by Application:
- Spinal Fusion Surgeries
- Delayed Union and Nonunion Bone Fractures
- Oral and Maxillofacial Surgeries
- Others
Breakup by End User:
- Hospitals and Clinics
- Home Care
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
